摘要
众所周知干扰素应答在慢性丙型感染病毒感染中是下调的。特别是几项研究表示那些患有慢性HCV感染具有干扰素刺激基因的高自然水平的的患者不能实现病毒的清除以及对于聚乙二醇化干扰素α和利巴韦林的治疗具有较差的应答性。与其他HCV感染患者相比,负责较高内源性的ISG表达的病毒和(或)宿主因子仍有待确定。然而, III型干扰素特别是新发现的拉姆达干扰素(L)4基因,似乎在驱动ISG反应和促进HSV持久性的建立中起主要作用。本综述的重点阐述近期ISG应答和IFNλ基因因子是如何影响HCV感染的临床结果,强调了在当前抗病毒治疗中使用直接抗病毒剂的影响。
关键词: 干扰素,干扰素刺激基因,白细胞介素-28B, 干扰素拉姆达4, 直接抗病毒剂, 先天免疫
图形摘要
Current Drug Targets
Title:Role of Interferons in Chronic Hepatitis C Infection
Volume: 18 Issue: 7
关键词: 干扰素,干扰素刺激基因,白细胞介素-28B, 干扰素拉姆达4, 直接抗病毒剂, 先天免疫
摘要: It is known that the production of and/or response to interferon (IFN) are deregulated during chronic hepatitis C virus (HCV) infection. In particular, several studies have shown that patients with chronic HCV infection who have a high natural level of IFN-stimulated genes (ISGs) do not achieve viral clearance and have a poor response to treatment with pegylated IFNα and ribavirin. The viral and/or host factors that are responsible for the higher endogenous ISGs expression in some HCV infected patients compared to others remain to be determined. However, type III IFNs, and in particular the new discovered IFN lambda (L) 4 Gene, appear to play a dominant role in driving ISGs response and in contributing to the establishment of HCV persistence. This review focuses on recent studies on how the ISGs response and the IFNλ genetic factors (interleukin-28B and IFNL4) affect the clinical outcome of HCV infection highlighting their impact in the current antiviral therapies with direct acting antiviral agents.
Export Options
About this article
Cite this article as:
Role of Interferons in Chronic Hepatitis C Infection, Current Drug Targets 2017; 18 (7) . https://dx.doi.org/10.2174/1389450117666160201112632
DOI https://dx.doi.org/10.2174/1389450117666160201112632 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Regulation of Angiogenesis by Macrophages, Dendritic Cells, and Circulating Myelomonocytic Cells
Current Pharmaceutical Design Epigenetic Regulation of Myocardial Homeostasis, Self-Regeneration and Senescence
Current Drug Targets New Adamantane Derivatives with Sigma Affinity and Antiproliferative Activity
Medicinal Chemistry Recent Advances in Endocrine Metabolic Immune Disorders Drug Targeting: An Editorial Overview
Endocrine, Metabolic & Immune Disorders - Drug Targets Non-Specific Microbicide Product Development: Then and Now
Current HIV Research Glutamatergic Neurotransmission As Molecular Target of New Anticonvulsants
Current Topics in Medicinal Chemistry Sesame Seed Lignans: Potent Physiological Modulators and Possible Ingredients in Functional Foods & Nutraceuticals
Recent Patents on Food, Nutrition & Agriculture Pathophysiology of Atherosclerosis: The Role of Inflammation
Current Pharmaceutical Design Mitochondrial-Associated Metabolic Changes and Neurodegeneration in Huntingtons Disease - from Clinical Features to the Bench
Current Drug Targets Cytochrome P450 Drug Metabolizing Enzymes in Roma Population Samples: Systematic Review of the Literature
Current Medicinal Chemistry The Role of Melatonin in Pancreatic Protection: Could Melatonin be Used in the Treatment of Acute Pancreatitis?
Current Pharmaceutical Design A Prioritization Method for Identifying Disease-Causative Gene Based on Hyper Graph Network
Current Proteomics Encapsulation of Liquids Via Extrusion - A Review
Current Pharmaceutical Design Src Family Kinases as Regulators of Angiogenesis: Therapeutic Implications
Current Cancer Therapy Reviews Microporation Techniques for Enhanced Delivery of Therapeutic Agents
Recent Patents on Drug Delivery & Formulation Target Based Drug Design - A Reality in Virtual Sphere
Current Medicinal Chemistry Recent Updates in the Alzheimer’s Disease Etiopathology and Possible Treatment Approaches: A Narrative Review of Current Clinical Trials
Current Molecular Pharmacology Pharmacological Management Options to Prevent and Reduce Ischemic Hemorrhagic Transformation
Current Drug Targets Disposition of Flavonoids Impacts their Efficacy and Safety
Current Drug Metabolism Protease Inhibitors in the Clinic
Medicinal Chemistry